Loading…
CIK 0001643354 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("lion-point-capital-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC | COM | $152K | 0.8%Prev: 3.8% | 5,250 SH | Decreased-30,050 SH |
| ARDELYX INC | COM | $750K | 3.9%Prev: 5.1% | 128,650 SH | Decreased-34,100 SH |
| AZENTA INC | COM | $323K | 1.7% | 9,700 SH | New |
| BENITEC BIOPHARMA INC | COM NEW | $835K | 4.3%Prev: 4.9% | 62,000 SH | Decreased |
| BIOHAVEN LTD | COM | $584K | 3.0%Prev: 1.9% | 51,700 SH | Increased+29,000 SH |
| BRIDGEBIO PHARMA INC | COM | $382K | 2.0%Prev: 3.9% | 5,000 SH | Decreased-8,300 SH |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $400K | 2.1%Prev: 1.9% | 58,000 SH | Increased |
| CUE BIOPHARMA INC | COM | $673K | 3.5% | 2,202,854 SH | New |
| DAY ONE BIOPHARMACEUTICALS I | COM | $391K | 2.0%Prev: 1.7% | 42,000 SH | Increased |
| DISC MEDICINE INC | COM | $643K | 3.3%Prev: 4.0% | 8,100 SH | Decreased-2,500 SH |
| DYNE THERAPEUTICS INC | COM | $352K | 1.8% | 18,000 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $226K | 1.2% | 9,100 SH | New |
| FENNEC PHARMACEUTICALS INC | COM | $866K | 4.5%Prev: 6.5% | 112,434 SH | Decreased-10,566 SH |
| GERON CORP | COM | $763K | 3.9%Prev: 3.9% | 578,000 SH | Increased+78,000 SH |
| GH RESEARCH PLC | ORDINARY SHARES | $130K | 0.7% | 10,200 SH | New |
| HUMACYTE INC | COM | $480K | 2.5%Prev: 0.8% | 500,000 SH | Increased+416,500 SH |
| INNATE PHARMA S A | SPONSORED ADS | $142K | 0.7% | 81,151 SH | New |
| INNOVIVA INC | COM | $164K | 0.8% | 8,200 SH | New |
| JANUX THERAPEUTICS INC | COM | $262K | 1.4% | 19,000 SH | New |
| JASPER THERAPEUTICS INC | COM NEW | $851K | 4.4%Prev: 5.4% | 465,000 SH | Decreased+66,442 SH |
| KURA ONCOLOGY INC | COM | $478K | 2.5%Prev: 2.3% | 46,000 SH | Increased |
| LANTHEUS HLDGS INC | COM | $366K | 1.9% | 5,500 SH | New |
| MERSANA THERAPEUTICS INC | COM | $3K | 0.0%Prev: 1.1% | 100 SH | Decreased-25,660 SH |
| MILESTONE PHARMACEUTICALS IN | COM | $1.5M | 7.9%Prev: 7.5% | 755,000 SH | Increased+96,447 SH |
| MINERALYS THERAPEUTICS INC | COM | $381K | 2.0%Prev: 8.4% | 10,500 SH | Decreased-28,500 SH |
| MINERVA NEUROSCIENCES INC | COM NEW | $141K | 0.7% | 35,000 SH | New |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $890K | 4.6%Prev: 2.7% | 67,500 SH | Increased |
| PACIRA PHARMACEUTICALS INC | COM | $349K | 1.8% | 13,500 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $1.3M | 6.8%Prev: 1.7% | 4,450 SH | Increased-1,250 SH |
| REGENXBIO INC | COM | $383K | 2.0%Prev: 3.2% | 26,600 SH | Decreased-31,150 SH |
| ROCKET PHARMACEUTICALS INC | COM | $302K | 1.6%Prev: 1.6% | 86,000 SH | Increased |
| ROYALTY PHARMA PLC | SHS CLASS A | $827K | 4.3%Prev: 4.3% | 21,400 SH | Increased |
| SAREPTA THERAPEUTICS INC | COM | $613K | 3.2% | 28,500 SH | New |
| SERES THERAPEUTICS INC | COM NEW | $470K | 2.4%Prev: 3.0% | 31,570 SH | Decreased+4,432 SH |
| SPRUCE BIOSCIENCES INC | COM NEW | $87K | 0.5%Prev: 0.1% | 1,000 SH | Increased |
| SYNDAX PHARMACEUTICALS INC | COM | $756K | 3.9%Prev: 4.8% | 36,000 SH | Decreased-19,000 SH |
| UNIQURE NV | SHS | $352K | 1.8% | 14,700 SH | New |
| VENTYX BIOSCIENCES INC | COM | $375K | 1.9% | 41,500 SH | New |
| VIATRIS INC | COM | $345K | 1.8% | 27,700 SH | New |
| 13F-HR |
| 0001013594-26-000908 |
| $20.9M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001013594-25-001032 | $14.7M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001013594-26-000605 | $16.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001013594-25-000673 | $15.7M | View |